Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

May 27, 2020

Dr. Rachna Patel moved from a career as an emergency room doctor to become a medical marijuana doctor treating patients with a combination of cannabinoids like CBD and THC.  She shares her insights about how the brain processes pain, how cannabinoids can reduce inflammation in the body, and how cannabinoids can impact...


May 27, 2020

Dr. Rachna Patel moved from a career as an emergency room doctor to become a medical marijuana doctor treating patients with a combination of cannabinoids like CBD and THC.  She shares her insights about how the brain processes pain, how cannabinoids can reduce inflammation in the body, and how cannabinoids can impact...


May 26, 2020

Jeff Stein, President and CEO, Cidara Therapeutics talks about  their antifungal platform rezafungin now in Phase 3 clinical development to address the needs of the vulnerable population of patients hospitalized for something else who get a life-threatening fungal infection in the hospital. Jeff also explains their...


May 26, 2020

Jeff Stein, President and CEO, Cidara Therapeutics talks about  their antifungal platform rezafungin now in Phase 3 clinical development to address the needs of the vulnerable population of patients hospitalized for something else who get a life-threatening fungal infection in the hospital. Jeff also explains their...


May 20, 2020

Dr. Barbara Klencke, Chief Development Officer, Sierra Oncology talks about the development of momelotinib for myelofibrosis, a rare blood cancer.  Momelotinib's unique mechanism of action allows it to address all three key symptoms of myelofibrosis, including the debilitating anemia which can be exacerbated by...